Composition and method for enhancing transport across gastrointestinal tract cell layers
    1.
    发明授权
    Composition and method for enhancing transport across gastrointestinal tract cell layers 有权
    促进胃肠道细胞层转运的组合物和方法

    公开(公告)号:US06423334B1

    公开(公告)日:2002-07-23

    申请号:US09163510

    申请日:1998-09-30

    IPC分类号: A61K900

    摘要: A composition for enteral administration having a non-ionic vegetable oil GIT absorption enhancer capable of increasing the enteral absorbability of drugs, especially oral absorbability of hydrophilic and macromolecular drugs. The non-ionic vegetable oil GIT absorption enhancer, particularly Babassu oil or a derivative thereof, is capable of enhancing the uptake of a drug from the gastrointestinal tract so as to allow therapeutically effective amounts of the drug to be transported across the GIT of an animal such as a human without significant toxic side effects.

    摘要翻译: 一种用于肠内给药的组合物,其具有能够增加药物的肠内吸收性的非离子植物油GIT吸收促进剂,特别是亲水性和大分子药物的口服吸收性。 非离子植物油GIT吸收促进剂,特别是巴布苏油或其衍生物能够增强药物从胃肠道的摄取,以便允许治疗有效量的药物跨越动物的GIT转运 如人体无明显毒副作用。

    METHOD FOR INDUCING A CELL-MEDIATED IMMUNE RESPONSE AND IMPROVED PARENTERAL VACCINE FORMULATIONS THEREOF
    2.
    发明申请
    METHOD FOR INDUCING A CELL-MEDIATED IMMUNE RESPONSE AND IMPROVED PARENTERAL VACCINE FORMULATIONS THEREOF 审中-公开
    用于诱导细胞介导的免疫应答的方法及其改良的外源性疫苗制剂

    公开(公告)号:US20080254134A1

    公开(公告)日:2008-10-16

    申请号:US12144130

    申请日:2008-06-23

    申请人: David J. Brayden

    发明人: David J. Brayden

    IPC分类号: A61K9/14 A61K39/00 A61K39/10

    摘要: A method of inducing either a TH1 polarised immune response, a TH2 polarised immune response or a combined TH1 and TH2 response to an antigen and associated vaccine formulations are disclosed. A method is provided for inducing a polarised TH1 response by parenteral administration of microparticles sized such that at least 50% of the microparticles are less than 5 μm, the microparticles containing antigen entrapped or encapsulated by a biodegradable polymer. Additionally, a method is provided for inducing a polarised TH2 response by parenteral administration of nanoparticles sized such that at least 50% of the nanoparticles are less than 600 nm, the nanoparticles containing antigen entrapped or encapsulated by a biodegradable polymer. Vaccine formulations containing the B. pertussis antigens PTd, FHA or a combination of PTd and FHA are provided.

    摘要翻译: 诱导T 1 H 1偏振免疫应答,T H 2 H 2极化免疫应答或组合T H H 1和T H 1的极性免疫应答的方法, 公开了对抗原和相关疫苗制剂的反应。 提供了通过胃肠外给药微粒的尺寸使得至少50%的微粒小于5μm的微粒诱导极化的T H 1应答的方法,所述微粒含有被生物降解的包裹的抗原 聚合物。 此外,提供了一种通过胃肠外施用纳米粒子来诱导极化T H 2 H 2应答的方法,所述纳米颗粒的尺寸使得至少50%的纳米颗粒小于600nm,所述纳米颗粒含有被包被或被 可生物降解的聚合物。 提供含有百日咳杆菌抗原PTd,FHA或PTd和FHA的组合的疫苗制剂。

    Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
    3.
    发明授权
    Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof 有权
    用于诱导细胞介导的免疫应答的方法和其改进的肠胃外疫苗制剂

    公开(公告)号:US07087236B1

    公开(公告)日:2006-08-08

    申请号:US09386266

    申请日:1999-08-31

    申请人: David J. Brayden

    发明人: David J. Brayden

    摘要: A method of inducing either a TH1 polarized immune response, a TH2 polarized immune response or a combined TH1 and TH2 response to an antigen and associated vaccine formulations are disclosed. A method is provided for inducing a polarized TH1 response by parenteral administration of microparticles sized such that at least 50% of the microparticles are less than 5 μm. The microparticles containing antigen entrapped or encapsulated by a biodegradable polymer. Additionally, a method is provided for inducing a polarized TH2 response by parenteral administration of nanoparticles sized such that at least 50% of the nanoparticles are less than 600 nm, the nanoparticles containing antigen entrapped or encapsulated by a biodegradable polymer. Vaccine formulations containing the B. pertussis antigens PTd, FHA or a combination of PTd and FHA are provided.

    摘要翻译: 诱导T 1 H 1偏振免疫应答,T H 2 H 2极化免疫应答或组合T H H 1和T H 1的极性免疫应答的方法, 公开了对抗原和相关疫苗制剂的反应。 提供了通过肠胃外给药微粒的尺寸使得至少50%的微粒小于5μm的诱导极化T H 1 H应答的方法。 含有由可生物降解聚合物包埋或包封的抗原的微粒。 此外,提供了一种通过胃肠外施用纳米粒子来诱导极化T H 2 H 2应答的方法,所述纳米颗粒的尺寸使得至少50%的纳米颗粒小于600nm,所述纳米颗粒含有被包被或被 可生物降解的聚合物。 提供含有百日咳杆菌抗原PTd,FHA或PTd和FHA的组合的疫苗制剂。